AI drug discovery

3 articles

Anthropic Pivots to Pharma: AI Giant Plans to Develop Its Own Drugs

Anthropic Pivots to Pharma: AI Giant Plans to Develop Its Own Drugs

Anthropic is building its own wet labs and hiring biologists to develop drugs for neglected diseases. The move puts the AI giant in direct competition with the pharma companies it wants as customers, proving the race for AI medicine is moving from software to the physical lab....

MoleculeMind MMDesign Hits 90% Success Rate in AI Nanobody Design

MoleculeMind MMDesign Hits 90% Success Rate in AI Nanobody Design

Traditional antibody discovery is a needle-in-a-haystack process. MoleculeMind just hit a 90.9% success rate with its MMDesign platform, conquering complex TNF alpha targets with just 14 candidates. AI is turning random screening into programmable engineering....

Advertisement